Patient Guide: Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 38 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06651281
Status: 🟢 Enrolling Now
Condition: Crohn Disease, Colitis, Ulcerative
Phase: PHASE3

Where You Can Participate

This study is available at 38 locations across the country.

Top locations include:
  • • Bristol, Connecticut
  • • Ypsilanti, Michigan
  • • Liberty, Missouri
  • • And 35 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011) - Join Clinical Trial NCTNCT06651281

How to Join This Clinical Trial - NCTNCT06651281

Learn how to participate in this PHASE3 trial studying an investigational therapy for Crohn Disease, Colitis, Ulcerative. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Crohn Disease, Colitis, Ulcerative. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Crohn Disease, Colitis, Ulcerative
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06651281 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 38 locations. Find a study site near you:

Clinical Research Site

Bristol, Connecticut 06010 - United States

Status: RECRUITING

Clinical Research Site

Ypsilanti, Michigan 48197 - United States

Status: RECRUITING

Clinical Research Site

Liberty, Missouri 64068 - United States

Status: RECRUITING

Clinical Research Site

New York, New York 10075 - United States

Status: RECRUITING

Clinical Research Site

Garland, Texas 75044 - United States

Status: RECRUITING

Clinical Research Site

Lubbock, Texas 79410 - United States

Status: RECRUITING

Clinical Research Site

Lubbock, Texas 79424 - United States

Status: RECRUITING

Clinical Research Site

San Antonio, Texas 78229 - United States

Status: RECRUITING

Clinical Research Site

Southlake, Texas 76092-9167 - United States

Status: RECRUITING

Clinical Research Site

Tyler, Texas 75701 - United States

Status: RECRUITING

And 28 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Crohn Disease, Colitis, Ulcerative:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships